NCT07494851

Brief Summary

To assess the feasibility and inform the design and conduct of a pragmatically conducted, interventional, multi-centre RCT in adult patients admitted to UK major trauma centres with rib fractures examining ESP block as an analgesic adjunct to existing multimodal analgesia in the early management of rib fracture pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 15, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

December 15, 2025

Last Update Submit

March 20, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Recruitment rate vs target

    Defined as the number of eligible participants who consent to participate in the trial as a percentage of all eligible participants. This will be presented per centre per month and measured over the recruitment period (from randomisation of the first participant to randomisation of the 50th participant). The target recruitment rate is defined as recruitment of 50 participants from three recruiting centres, with each centre being open to recruitment for 12 months. This produces a mean trial target recruitment rate of 1.4 participants per centre per month.

    18 months

  • Retention rate

    Defined as the proportion of randomised participants who complete 6-week follow-up with valid candidate clinical outcomes data. Barriers and facilitators to recruitment and retention among participants and recruitment site staff (anaesthetists, allied health professionals, surgeons and research staff). This will be assessed in the embedded qualitative study.

    18 months

  • Qualitative feedback

    Qualitative research will be embedded within the ESPEAR RCT feasibility trial to provide insights into the feasibility and design of a main RCT trial. It will focus on two key aspects: Understanding the acceptability and feasibility of delivering the intervention/control in practice Exploring patients' experience of trial participation and acceptability of interventions The aim of this qualitative work is to enrich the quantitative data collected. The qualitative study intends to provide insight into processes used for research delivery and highlight where these processes vary between centres. Identification of barriers to recruitment will facilitate improvements in trial design should this feasibility trial proceed to a full trial. The trial will use multiple approaches to qualitative data-collection to optimize data collection.

    18 months

Secondary Outcomes (6)

  • Screening rate

    18 months

  • Eligibility rate

    18 months

  • Consent rate

    18 months

  • Protocol violations

    2 years

  • Trial withdrawals

    2 years

  • +1 more secondary outcomes

Study Arms (2)

ESP Block

ACTIVE COMPARATOR

ESP Block

Procedure: ESP Block

Placebo

PLACEBO COMPARATOR

Placebo

Procedure: ESP Block

Interventions

ESP BlockPROCEDURE

ESP block

ESP BlockPlacebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 Mechanism of injury blunt thoracic trauma Radiographic evidence of 1 or more new traumatic rib fractures Moderate or severe unilateral acute pain (defined as 11-point numerical rating scale (NRS) pain \>4 when patient performing vital capacity breath or effective cough) at time of enrolment. Patients may have bilateral fractures, but pain must be unilateral.

You may not qualify if:

  • Patient refusal or inability to give informed written consent for any reason Thoracic injury requiring emergent operative or interventional radiology management Allergy to local anaesthetic Infection at site of ESP block Actual or estimated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Barts Health NHS Trust

London, United Kingdom

Location

Manchester University NHS Foundation Trust

Manchester, United Kingdom

Location

Queens Medical Centre

Nottingham, United Kingdom

Location

MeSH Terms

Conditions

Rib Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesThoracic Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Only anesthetist will be un blinded. Research nurse and participant will be blinded to treatment arm.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2025

First Posted

March 27, 2026

Study Start

July 1, 2022

Primary Completion

February 12, 2024

Study Completion

February 12, 2024

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations